Organization · Venture Capital
RocketBio
RocketBio is a biotechnology investment firm specializing in tissue engineering and regenerative medicine. The firm partners closely with portfolio companies to foster sustainable growth and innovation in the biotech sector.
Overview
What RocketBio does
What RocketBio is
RocketBio is a biotechnology investment firm specializing in tissue engineering and regenerative medicine. The firm partners closely with portfolio companies to foster sustainable growth and innovation in the biotech sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find RocketBio elsewhere
Open the official website or a supported primary organization account.
Capability profile
RocketBio as a funder
Investment thesis
RocketBio is a biotechnology investment firm focused on tissue engineering and regenerative medicine, emphasizing long-term partnerships that bridge scientific breakthroughs with real-world medical solutions.
Focus narrative
RocketBio invests in companies within the biotech sector, specifically targeting tissue engineering and biotools. The firm collaborates with scale-ups and established operators that are moving toward commercialization and clinical translation. Their investment strategy emphasizes long-term partnerships, ensuring that scientific advancements translate into practical medical solutions.
Value beyond capital
RocketBio adds value to its portfolio companies through hands-on partnership, leveraging its expertise and connections in the biotech sector to support early customer engagement and facilitate the transition from scientific innovation to market-ready solutions.
Focus and fit
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 2
Portfolio context
VoxCell: A biotechnology company based in Victoria, Canada, that develops vascularized 3D bioprinted tissue models for precision oncology drug development. VoxCell's technology aims to replicate the complexity of human tumors to improve drug testing and candidate selection. Netri: A neurotechnology company located in Lyon, France, that creates human nerve-on-chip microphysiological systems. Netri's technology integrates human-derived neurons and microfluidics to enable predictive neuroscience and toxicology testing, aiming to reduce animal testing and accelerate drug development.
Common questions
What to know about RocketBio
Upseed classifies RocketBio under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.